Biogen Inc.
Location
Massachusetts
Founded
1978-02-28
Website
Risk Signals
6619 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Biological Products, Except Diagnostic Substances, Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Biogen Inc.
Live alerts from global media, monitored by Business Radar
2024-11-20 (biospace.com)
Facing a Dearth of Big Pharma Interest, Rare Disease Players Get Creative to Fund R&D
A handful of billion-dollar deals in the rare disease space highlights the uptick in Big Pharma’s investment, but it’s still extremely low compared to the money flowing to more common indications.
Read more
2024-07-26 (barrons.com)
E.U. Rejection of Alzheimer's Drug Is Bad News for Biogen Stock
European drug regulators rejected Biogen and Eisai's request for approval of their Alzheimer's medicine Leqembi, pointing to safety and efficacy issues that...
Read more